13FPulse
HT

HTFL HEARTFLOW INC

2026Q2 · CUSIP 42238D107 · Sector: Healthcare & Biotech

Piling in

Net holder growth ranks near the top of the market

Funds that own it
190
Institutions that reported holding it to the SEC
Net increase in holders
+23
Last quarter 167 → now 190
How unusual is that
Top 20%
Stronger buying than 85% of US stocks
What the filings say, in one paragraph

190 funds held HTFL at the end of 2026Q2, up 23 from the quarter before. That is stronger buying than 85.4% of US stocks — among the most piled-into names this quarter. On the business itself, revenue over the last 12 months was $176M(YoY +39.9%). HTFL has had 2 buying rushes in its history. It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2025Q4: holders=110 2026Q1: holders=167 2026Q2: holders=190 -57 -28.5 +0 +28.5 +57 99150200 25Q426Q126Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 2 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q2 Top 20%
2026Q1 Top 5%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
106
Change in large funds
+14
Total value they hold
$4.7B
Funds buying for the first time
52
Funds that sold out entirely
29
Price change that quarter
+95.0%
Funds holding puts (bearish)
2
Funds holding calls (bullish)
3

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
EPS (TTM)
$-3.17
EPS YoY
Revenue (TTM)
$0.2B
Revenue YoY
+39.9%
Net margin
ROE
Debt ratio
17.0%
FCF (TTM)
Dividend (TTM)
No dividend

As of 2025-12-31 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.